Aminoglycosides. (Streptomycin and the neomycin group).
D004352:Drug Resistance, Microbial; D005601:Framycetin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use*; D010303:Paromomycin / Q000627:therapeutic use; D013307:Streptomycin / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy
D005839:Gentamicins; D005601:Framycetin; D007612:Kanamycin; D010303:Paromomycin; D009355:Neomycin; D013307:Streptomycin